## Diagnosis: Ménière Disease in the Acute Phase ### Clinical Presentation **Key Point:** Ménière disease is characterized by the classic triad of episodic vertigo, fluctuating sensorineural hearing loss, and aural fullness/tinnitus. The acute phase can mimic SSNHL but has distinguishing features. ### Why This Is Ménière Disease (Not SSNHL) | Feature | This Patient | Ménière Disease | SSNHL | |---------|-------------|-----------------|-------| | **Hearing loss pattern** | Low-frequency SNHL (500–2000 Hz) | **Classic low-frequency SNHL** | Any frequency; flat or high-frequency more common | | **Ear fullness** | Present | **Classic symptom** | May be present | | **Vertigo** | Mild, present | **Present (episodic)** | Mild or absent | | **Otoscopy** | Normal | Normal | Normal | | **Onset** | Sudden, 3 days | Can be sudden in acute phase | Sudden (≤3 days) | | **Audiometric pattern** | Low-frequency dip | **Low-frequency dip (hallmark)** | Variable | **Clinical Pearl:** The combination of **low-frequency SNHL + ear fullness + vertigo** is the hallmark triad of Ménière disease. SSNHL typically presents with flat or high-frequency loss and minimal or no vertigo. Low-frequency sensorineural hearing loss (500–2000 Hz) is the **audiometric signature of Ménière disease**, not SSNHL. ### Pathophysiology **High-Yield:** Ménière disease results from **endolymphatic hydrops** — accumulation of endolymph in the membranous labyrinth of the inner ear. This distorts the basilar membrane preferentially at the apex (low-frequency region), explaining the characteristic low-frequency hearing loss. - Increased endolymphatic pressure → distortion of Reissner's membrane - Apical cochlear involvement → low-frequency SNHL - Saccular/utricular involvement → episodic vertigo - Aural fullness from elevated endolymphatic pressure ### Diagnostic Criteria (AAO-HNS 2015 — Definite Ménière Disease) 1. Two or more spontaneous episodes of vertigo (20 min–12 hours) 2. Audiometrically documented low- to mid-frequency SNHL in the affected ear 3. Fluctuating aural symptoms (hearing loss, tinnitus, or fullness) 4. Not better accounted for by another diagnosis **Note:** In the **acute phase** (first presentation), full criteria may not yet be met — this is termed "probable Ménière disease." The audiometric pattern and symptom triad are sufficient for clinical diagnosis. ### Why Other Options Are Incorrect - **A) SSNHL:** SSNHL is defined as ≥30 dB loss in ≥3 consecutive frequencies over ≤3 days. While the onset is acute, SSNHL does NOT classically present with low-frequency loss + vertigo + ear fullness as a triad. The low-frequency audiometric pattern strongly favors Ménière disease. - **C) Acute otitis media:** Normal otoscopy excludes this diagnosis. AOM would show a dull, erythematous tympanic membrane with conductive hearing loss (air-bone gap >20 dB). - **D) Perilymphatic fistula:** Typically follows barotrauma, Valsalva, or head trauma. No such history is given. Vertigo is usually severe and positional. ### Management of Acute Ménière Disease - **Acute attack:** Vestibular suppressants (diazepam, promethazine), antiemetics - **Long-term:** Low-sodium diet, diuretics (hydrochlorothiazide + triamterene), betahistine - **Refractory:** Intratympanic gentamicin or steroids; endolymphatic sac surgery **Mnemonic:** **Ménière = Low-frequency SNHL + Vertigo + Fullness + Tinnitus** — the "LVFT" triad distinguishes it from SSNHL. [cite: Cummings Otolaryngology – Head and Neck Surgery, 7th ed., Ch. 163; AAO-HNS Ménière Disease Guidelines 2020; Scott-Brown's Otorhinolaryngology, 8th ed.] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.